Efavirenz: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2026

10 March 2026

  • curprev 23:1523:15, 10 March 2026Ostermayer talk contribs 7,579 bytes +7,579 Created page with "Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to treat HIV-1. Once a cornerstone of first-line therapy, it has been largely replaced by integrase inhibitors (e.g., Dolutegravir) but remains widely used globally. It is notable for prominent neuropsychiatric side effects and significant drug interactions.<ref name="SustivaPI">Sustiva (efavirenz) [prescribing information]. Princ..."